Stocks
Versartis, Inc.VSAR
NASDAQHealthcareBiotechnology$1.19-2.52%
A clinical-stage biotechnology company that focused on developing long‑acting protein therapeutics for endocrine disorders, most notably treatments targeting growth hormone deficiency. The company’s lead program, somavaratan (VRS‑317), advanced through late‑stage clinical trials before setbacks resh...
Market Cap: $052W Range: $1.14 – $2.75
This page tracks all publicly disclosed congressional trades in Versartis, Inc. (VSAR), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 0 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-03-22 | BOB GIBBS | buy | $1K – $15K |